Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaishali Pharma Limited has submitted a quarterly compliance certificate to the NSE covering the period from April 1, 2025 to June 30, 2025. The certificate, issued by its registrar Bigshare Services Pvt. Ltd., confirms that Regulation 74(5) of the SEBI Depositories Regulations is not applicable to the company. This is because 100% of the company's shares are already held in dematerialised (demat) form. Additionally, no shareholder requests for rematerialisation were received during the quarter. The filing was signed by Company Secretary Vishwa Mekhia and the RTA's authorised signatory Vikas Singh.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms full demat holding of the company's shares, indicating good corporate governance practices.